BEAM NASDAQ
Beam Therapeutics Inc.
1W: +0.9%
1M: -16.4%
3M: -30.6%
YTD: -9.7%
1Y: +1.5%
3Y: +1.0%
5Y: -74.1%
$24.50
+0.11 (+0.45%)
Weekly Expected Move ±7.9%
$21
$23
$24
$26
$28
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships9
As Filer
counterparties named
1
As Counterparty
mentioned by others
3
Rel. Types
2021-07-07
Earliest Filing
2026-02-24
Latest Filing
partner: 6
acquirer: 2
target: 1
Counterparties (Filed by BEAM)
9 relationshipsCompanies named in BEAM's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Pfizer | PFE | partner | Partner entering an exclusive worldwide license and potential co-development agreement for a liver-targeted development | 2026-02-24 | View |
| Bio Palette Co., Ltd. | — | partner | Counterparty to Standby License Agreement with Beam Therapeutics Inc. and Kobe University. | 2026-02-12 | View |
| Kobe University | — | partner | Counterparty to Standby License Agreement with Beam Therapeutics Inc. and Bio Palette Co., Ltd. | 2026-02-12 | View |
| Bristol-Myers Squibb Company | BMY | acquirer | Completed acquisition of Orbital Therapeutics, Inc. | 2025-12-11 | View |
| Orbital Therapeutics, Inc. | — | target | Target company acquired by Bristol-Myers Squibb Company. | 2025-12-11 | View |
| Eli Lilly and Company | LLY | acquirer | Acquired opt-in rights to Verve's base editing programs for cardiovascular disease and purchased Beam stock. | 2023-10-31 | View |
| Verve Therapeutics, Inc. | VERV | partner | Beam's original collaborator whose base editing programs for cardiovascular disease were the subject of the asset transf | 2023-10-31 | View |
| Jefferies LLC | JEF | partner | Sales agent for the Company's at-the-market offering of common stock | 2023-05-10 | View |
| Jefferies LLC | JEF | partner | Sales agent for the Company's at-the-market offering of common stock | 2021-07-07 | View |
Mentioned As Counterparty
1 mentionsOther companies that named BEAM in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-04 | Earnings Release; Exhibits | View | |
| 2026-06-08 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-05 | Termination of Material Definitive Agreement | View | |
| 2026-02-24 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of | Agreement | View |
| 2026-02-12 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2026-02-05 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-12-11 | Completion of Acquisition or Disposition of Assets | Acquisition | View |
| 2025-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-03 | Unregistered Sales of Equity Securities | View | |
| 2025-06-06 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-10 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-03-10 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2024-12-09 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-12-06 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR